Skip to content

Epidaurus · Treatment Guide · Reproductive Services

Going abroad for —

IVF Quality

IVF quality and success rates

The country comparison

Which countries are best for ivf quality

The destinations ranked high→low under this lens — each with the reasoning behind its score, the cited evidence one click down, and its full report. The verdict is free; the report is the depth.

19 / 19 Countries ranked

Researched and assessed by the Epidaurus editorial pipeline against our published scale. A country below the rule is not yet assessed enough — never ranked last.

  1. 1 United Arab Emirates AE 4.5/5 Good The UAE demonstrates exceptional IVF quality across all clinical measures: live birth rates of 50-60% for women under 35 and 30-40% for ages 35-37 exceed Score 5 thresholds; 88% single embryo transfer rate at leading ... Full report
    The evidence behind this score 4 cited points
    • Abu Dhabi Department of Health reports 51% overall live birth rate in 2024 with 695 births across 14 licensed ART facilities; women under 35 achieve 50-60% live birth rates per cycle
    • Five international JCI-accredited fertility clinic groups (Bourn Hall, First IVF, HealthPlus Fertility, Orchid Fertility, American Hospital Dubai); multiple labs hold CAP accreditation; Dubai Fertility Centre holds Diamond-level ACI accreditation
    • Prof. Human Fatemi holds ESHRE subspecialist recognition with H-index 35 and 250+ publications; Dr. Michael Fakih has 35+ years' experience and 35,000+ IVF deliveries
    • Laboratory quality meets or exceeds international standards with CAP accreditation, EmbryoScope time-lapse imaging, NGS genetic testing, and rigorous quality control systems

    Read the full United Arab Emirates report →

  2. 2 Singapore SG 4.5/5 Good Singapore achieves excellent clinical safety (OHSS <1%), specialist credentials (FRCOG/FAMS standard with 10-20+ years experience), and research leadership (world firsts in IVF innovation). However, national per-cycle... Full report
    The evidence behind this score 6 cited points
    • KKIVF OHSS rate <1% in 2023, among lowest globally; multiple birth rate ~5% reflecting high single embryo transfer adoption
    • Specialists hold mandatory FRCOG/MRCOG + FAMS + MOH accreditation with >10 years experience; KKH delivered >11,100 babies since 1993
    • Per-transfer success rates: SGH ~40% fresh cycles, ~50% frozen; Alpha IVF 59% clinical pregnancy rate per frozen blastocyst
    • National per-cycle rates 2017-2021: 24% (under 30), 22.7% (30-34), 17.2% (35-39), below Score 5 thresholds of >50%, >40%, >30%
    • Three clinics RTAC-accredited (Thomson, Raffles, Monash) with independent external audit; all MOH-licensed with mandatory R-DAR reporting
    • Research leadership: KKH world's first in vitro maturation live birth (2012); NUH leads national PGT-A pilot; CREST first Asia-Pacific ART training center (565 practitioners trained)

    Read the full Singapore report →

  3. 3 Thailand TH 4.5/5 Good Thailand demonstrates excellent IVF quality across most measurable dimensions, with leading clinics achieving live birth rates of 50-65% for women under 35 (exceeding the Score 5 threshold), extensive international ac... Full report
    The evidence behind this score 6 cited points
    • Live birth rates 40-65% per cycle with leading centers achieving 50-70% for women under 35; SAFE Fertility Group reports 70-80% for PGT-tested embryos
    • 38 JCI-accredited hospitals plus specialized fertility clinics with RTAC, AACI, and ISO certifications—significantly exceeds the 5+ accreditation requirement
    • Over 90% of fertility specialists in Bangkok's leading clinics hold international certifications from US, UK, or Australia; documented specialists with 10-18 years experience
    • Mandatory national ART registry with all licensed centers required to submit annual outcome reports to Royal Thai College of Obstetricians and Gynaecologists
    • Multiple clinics with ISO 15189/15190 laboratory certifications and ESHRE-designed embryology labs meeting international standards
    • Data gap identified: single embryo transfer rates not publicly reported nationally; OHSS-specific rates not transparently tracked in registry

    Read the full Thailand report →

  4. 4 United States US 4.5/5 Good The United States demonstrates exceptional IVF quality with live birth rates of 49.7% per successful egg retrieval for women under 35 (just below the Score 5 threshold of >50%), 36.3% for ages 35-37, and 23.1% for age... Full report
    The evidence behind this score 6 cited points
    • Live birth rates per successful egg retrieval: 49.7% (under 35), 36.3% (35-37), 23.1% (38-40) — within Score 4 range, approaching Score 5
    • Single embryo transfer rate: 73.9% in 2022 (Score 4 range of 60-80%)
    • Laboratory accreditation: 88% of U.S. labs have CAP accreditation, representing ~402 accredited clinics far exceeding the 5+ clinics required for Score 5
    • Comprehensive national surveillance: NASS captures 98% of all ART cycles with mandatory outcome reporting required by the Fertility Clinic Success Rate and Certification Act of 1992
    • Physician training: Reproductive endocrinologists complete 15+ years of education including 4 years medical school, 4-year OB/GYN residency, and 3-year REI fellowship with board certification
    • OHSS safety: Less than 5% of women undergoing IVF experience OHSS, with severe cases occurring in less than 1%

    Read the full United States report →

  5. 5 Spain ES 4.0/5 Good Spain demonstrates strong IVF infrastructure with 90% single embryo transfer (exceeding Score 5 standards) and exceptional donor-egg outcomes (83.2% live birth for women under 35). However, own-egg clinical pregnancy ... Full report
    The evidence behind this score 4 cited points
    • SEF national registry: 34-35% clinical pregnancy per transfer for women under 40; 90% single embryo transfer rate in blastocyst cycles; 50% clinical pregnancy rate with fresh embryos nationally
    • Dexeus Mujer: dual ESHRE accreditation (clinical/laboratory practice + subspecialist training); Instituto Bernabeu: 63.8% positive pregnancy test for women under 35; Institut Marquès: 83.2% live birth rate for donor-egg IVF under 35
    • ESHRE 2019 delivery rate: 16.4% per fresh aspiration cycle; twin delivery rate 11.0% vs European average 11.9%, indicating safe stimulation protocols
    • Research contributions: IVIRMA presented 37 studies at ASRM 2023; Instituto Bernabeu received ASEBIR national research award three times; 2025 analysis found transparency gap—only 1 of 5 clinics reviewed reported live birth rates publicly

    Read the full Spain report →

  6. 6 United Kingdom GB 4.0/5 Good The UK achieves excellent performance across nearly all quality dimensions: 88% single embryo transfer (exceeds Score 5 threshold of 80%), severe OHSS <0.1% (far below the 3% threshold), world-leading regulatory frame... Full report
    The evidence behind this score 6 cited points
    • Single embryo transfer rate 88% (exceeds Score 5 threshold of 80%) with multiple birth rate of 3.4%, one of the lowest globally
    • Severe OHSS <0.1% of cycles, far below 3% threshold, with robust British Fertility Society 2024 prevention guidelines
    • All 107 fertility treatment clinics HFEA-licensed with biennial inspections, transparent clinic-specific outcome reporting by age group, and publicly searchable success rates; HFEA Register is world's longest-running ART database since 1991
    • RCOG Reproductive Medicine subspecialty training requires MD/PhD plus MRCOG with seven years specialist training; embryologists require HCPC registration via NSHCS Scientist Training Programme
    • ISO 17025:2017 and ISO 9001:2015 laboratory accreditation; ARCS Good Practice in Clinical Embryology Guidelines 2024 implemented across sector
    • Cumulative live birth rates of 65–68% for under-35s across three cycles (Score 5 level); national live birth rate per fresh embryo transferred 35% under-35, 26% for 35–37, 18% for 38–39 reflects deliberate SET prioritization rather than poor quality

    Read the full United Kingdom report →

  7. 7 Japan JP 4.0/5 Good Japan demonstrates strong IVF quality with FET live birth rates of 28.8% per transfer and cumulative rates reaching 58.4% for women under 35 over multiple cycles, combined with world-leading single embryo transfer rat... Full report
    The evidence behind this score 6 cited points
    • FET live birth rate 28.8% per transfer in 2023; cumulative rate 58.4% for women under 35 over 6 cycles (Assisted Reproductive Technology in Japan 2023 - JSOG)
    • SET rates 80.5% (fresh) and 84.7% (FET) among the highest globally, with singleton live birth rates above 96% (Assisted Reproductive Technology in Japan 2023 - JSOG)
    • OHSS rate below 1% in large Japanese cohorts, significantly below the 3% threshold (Individualized Follitropin Delta Dosing - PubMed 2021)
    • 31 JISART-accredited clinics with ISO 9001 certification and triennial 245-point audits covering 245 quality criteria (Audit and Accreditation of ART Facilities in Japan - JISART 2022)
    • JSOG national registry with 98% facility participation (625 of 638 clinics) since 1986, with mandatory annual reporting (Assisted Reproductive Technology in Japan 2023 - JSOG)
    • Ranked top 5 globally for ICSI research contribution; evidence-based treatment protocols with 59.8% freeze-all adoption (Bibliometric Analysis of ICSI Research - PMC 2023)

    Read the full Japan report →

  8. 8 South Korea KR 4.0/5 Good South Korea demonstrates excellent IVF clinical outcomes with leading clinics reporting 50-65% success rates for women under 35, well-established national data collection across 201 certified institutions, board-certi... Full report
    The evidence behind this score 5 cited points
    • Leading fertility clinics report pregnancy success rates of 50-60% per embryo transfer, significantly exceeding the global average and meeting Score 5 thresholds for women under 35
    • OHSS incidence of 5.4% in fresh embryo transfers (2017-2022 national data) exceeds the <3% benchmark for Score 5 but falls within the 3-5% acceptable range for Score 4
    • Comprehensive national IVF registry established in 2018, collecting data from 201 certified institutions with national insurance coverage since 2017
    • CHA Fertility Center certified by South Korean Ministry of Health and Welfare for 120 safe therapy standards (only facility among 368 with this certification), plus JCI-accredited centers, though specific count of 5+ JCI clinics not documented
    • Board-certified reproductive endocrinologists with subspecialty training, including 17 board-certified specialists at major CHA center, supporting professional standards

    Read the full South Korea report →

  9. 9 Malaysia MY 4.0/5 Good Malaysia demonstrates strong IVF quality across clinical expertise, laboratory standards, and accreditation—with 8 RTAC-certified clinics (exceeding the 5+ threshold) and specialists holding FRCOG/MRCOG qualifications... Full report
    The evidence behind this score 6 cited points
    • Eight RTAC-accredited fertility clinics—the highest concentration outside Australia and New Zealand—indicating exceptional third-party validation of laboratory and clinical quality
    • Live birth rates approximately 46% for women under 35, aligned with Cleveland Clinic benchmarks but below the >50% threshold for Score 5
    • Clinical specialists with FRCOG/MRCOG qualifications and 15–25+ years of fertility experience; average specialist training exceeds 20 years at leading clinics
    • No national IVF registry exists; all published success rates are clinic self-reported without independent verification, creating transparency gaps for international patients
    • Mean single embryo transfer rate of 2.0 per cycle at leading clinics; no national SET mandate despite evidence-based momentum toward SET practices
    • Laboratory technology including NGS preimplantation genetic testing, time-lapse embryo monitoring, vitrification with 90–100% post-thaw survival, and IMSI sperm selection

    Read the full Malaysia report →

  10. 10 Poland PL 4.0/5 Good Poland demonstrates strong IVF quality driven by world-class elite clinics (Gameta as Europe's first ESHRE-certified clinic, Invicta with ISO 15189 accreditation) paired with solid national infrastructure. Single embr... Full report
    The evidence behind this score 5 cited points
    • Klinika Bocian reports 62% live birth rate for women under 35 and 47% for ages 35-40, meeting Score 5 thresholds at elite level [IVF Success Rate in Poland: the Best Clinic - Klinika Bocian - 2025]
    • Gameta is the first ESHRE-certified fertility clinic in all of Europe; Invicta holds ISO 15189, ISO 9001, ISO 14001 accreditations [About Gameta / Effective IVF treatment in Poland - 2024]
    • National OHSS rate of 0.34% (2013-2016) is exceptionally low, well below the 3% Score 5 threshold, indicating excellent safety protocols [Assisted reproductive medicine in Poland, 2013-2016 - PTMRiE/SPiN PTGiP - 2021]
    • Single embryo transfer rate of 66.9% (2019) falls squarely in Score 4 range (60-80%) and reduces multiple birth risks [ART in Europe, 2019 - ESHRE - PMC - 2023]
    • PTMRiE explicitly noted absence of centralized national ART database prevents fully reliable assessment of treatment quality; mandatory comprehensive national registry is a Score 5 requirement [Assisted reproductive medicine in Poland, 2013-2016 - PubMed - 2021]

    Read the full Poland report →

  11. 11 India IN 3.5/5 Moderate India demonstrates strong capability at leading fertility centers with 40–50% live birth rates for women under 35, qualified reproductive endocrinologists (FNB certification), and 2–3 internationally accredited clinic... Full report
    The evidence behind this score 5 cited points
    • Leading clinics report 40–50% live birth rates per cycle for women under 35 (Nova IVF, Indira IVF); national average 30–40% across all registered centers
    • Only 2–3 internationally accredited fertility centers: BirthRight by Rainbow Hospitals (JCI), Apollo Fertility Bengaluru (JCI/QAI), Yellow Fertility Gurgaon (NABH accreditation 2024)
    • Single embryo transfer rates approximately 10–12% at leading clinics and historically 10% nationally, versus 60–80% benchmark for Score 4
    • No publicly available comprehensive national IVF outcome registry; last formal NARI publication covered 2007–2009 data; mandatory registry under 2021 ART Act has not published comparative outcome data as of mid-2025
    • Qualified specialist cadre: FNB Reproductive Medicine (2-year post-doctoral, ~7–8 competitive seats nationally); ISAR 7,500+ members; leading specialists participate in ESHRE and ASRM; Indian contributions to ICMART global ART dataset

    Read the full India report →

  12. 12 Israel IL 3.5/5 Moderate Israel has world-class flagship fertility centers (Sheba, Hadassah, Sourasky, Rambam) with exceptional specialist expertise (40+ years experience), 5+ JCI-accredited clinics, and innovation leadership (AIVF, QART Medi... Full report
    The evidence behind this score 7 cited points
    • Population-level live birth rates (Maccabi 67,059 cycles): 24–27% for women <35, 16% for ages 35–39, below Score 4 thresholds of 40–50% and 30–40%
    • 5+ JCI-accredited fertility centers (Assuta, Sheba, Sourasky, Hadassah, Rambam) with international quality benchmarking
    • Faculty-level specialists: Prof. Foad Azem (40 years, 4,000+ successful pregnancies), Prof. Alexander Simon (43 years, 5,000+ procedures)
    • Single embryo transfer rate estimated <40%, well below Score 4 requirement of 60–80%; mean 1.2 live births per delivery indicates high multiple-pregnancy rates
    • State Comptroller (Nov 2024) declared IVF oversight a 'fundamental failure'; deficiencies from 2018–2019 unresolved prior to Sept 2022 embryo mix-up at Assuta Rishon LeZion
    • Advanced laboratory technology (Embryoscope time-lapse, AI embryo scoring) at flagship centers; innovation leadership (AIVF: 38% accuracy improvement; QART Medical: 34%→65% pregnancy rate in trials)
    • No comprehensive national IVF outcomes registry; success rates largely self-reported by individual clinics using varying methodologies

    Read the full Israel report →

  13. 13 Brazil BR 3.5/5 Moderate Brazil demonstrates moderate-to-good IVF quality infrastructure with 58 REDLARA-accredited centers, formal subspecialty training through FEBRASGO, and large cycle volume (50,000+ annually). However, significant weakne... Full report
    The evidence behind this score 6 cited points
    • 58 REDLARA-accredited centers (38.1% of all REDLARA sites globally) demonstrating significant international quality recognition
    • REDLARA registry delivery rates of ~24% per fresh embryo transfer and ~30% per frozen embryo transfer (2019 data with Brazil contributing 46% of cycles)
    • Single embryo transfer rate of only 38.3% producing twin rates of 26%, far exceeding 5-10% ESHRE/ASRM targets—a major quality concern
    • Zero of 161 Brazilian fertility clinics publish live birth rates; only 33.5% publish any success rate metrics—critical transparency failure
    • Human reproduction recognized as formal FEBRASGO subspecialty with board certification (TEGO); leading clinics operate 25-35 years with substantial experience
    • Mandatory SisEmbrio registry requires all 193+ clinics to report cycle volumes and embryo production; ANVISA laboratory regulation (RDC 33/23) and CFM 2294/21 embryo transfer limits provide institutional oversight

    Read the full Brazil report →

  14. 14 Colombia CO 3.5/5 Moderate Colombia's leading fertility centers (InSer, Reprotec) deliver internationally accredited care with modern protocols and reported clinical pregnancy rates of 40–65%, meeting Score 4 standards for clinical expertise an... Full report
    The evidence behind this score 6 cited points
    • InSer holds JCI, AAAASF, GHA (renewed 2024), and REDLARA accreditation; Reprotec holds ISO 9001 (unique in Colombia) and ESHRE/ASRM membership — 2–3 clinics with strong international accreditation, below the 5+ required for Score 5
    • Reported success rates at leading clinics range 40–65% clinical pregnancy per cycle; Babynova estimates ~40% under 35, 25–30% ages 35–39, and 10–15% over 40, but these are clinical pregnancy rates and live birth rate data by age group are not published
    • No mandatory national ART outcome registry exists; only 14 of ~50 Colombian fertility clinics report to REDLARA voluntarily, creating a transparency gap where the majority operate without publicly available outcome data
    • No published national data on SET %, multiple birth rates, or OHSS rates; regional REDLARA data (2019) show 26.4% twin rate in Latin America, suggesting SET adoption lags significantly behind international benchmarks
    • CECOLFES's research contributions (first IVF live birth in Latin America 1985, pioneering stem cell work) demonstrate scientific capacity, and leading specialists have international training, but regulatory framework remains weak (Decree 1546/1998 not updated; Law 1953/2019 implementation incomplete)
    • Report explicitly identifies 'the absence of a mandatory national IVF outcome registry' as 'the most significant structural concern for medical tourists,' indicating that regulatory environment does not uniformly protect patients outside accredited centers

    Read the full Colombia report →

  15. 15 Germany DE 3.5/5 Moderate Germany operates a technically sophisticated IVF system with excellent laboratory standards (ISO 15189 accreditation via DAkkS, ESHRE certification) and qualified specialists (AGRBM 6+ years experience requirement), b... Full report
    The evidence behind this score 5 cited points
    • Live birth rates: 22.5% per fresh embryo transfer nationally (2022); 30.9% for women aged 30-34; cumulative >80% pregnancy within 4 cycles for women under 34
    • Laboratory quality: ISO 15189 accreditation via DAkkS; ESHRE ART Centre Certification; time-lapse embryoscopy and ICSI capabilities at major centers
    • Clinical expertise: Bundesärztekammer-supervised subspecialty training; AGRBM requires ≥6 years experience or ESHRE Senior Embryologist qualification; Germany ranks 5th in European ART research output
    • Single embryo transfer trend: Dramatic improvement from 34.4% SET rate in 2019 to multiple birth rate of 8% overall in 2023, breaking the 10% threshold for first time
    • Outcome transparency limitation: D·I·R provides aggregate national data only; individual clinic success rates not publicly disclosed; 15.1% of outcomes from reporting centers undocumented (2014 audit)

    Read the full Germany report →

  16. 16 Jordan JO 3.0/5 Moderate Jordan demonstrates moderate IVF quality marked by world-class leading specialists and some JCI-accredited flagship institutions, but is held back by verified success rates well below the moderate threshold (14.1% liv... Full report
    The evidence behind this score 5 cited points
    • Independent peer-reviewed study found 14.1% live birth rate from 2,059 ICSI cycles, below Score 3 minimum for most age groups
    • Multiple-birth rates of 22.7% twins and 4.5% triplets indicate <40% single embryo transfer rate (explicit red flag in rubric)
    • Jordan Hospital and Jordan University Hospital hold JCI accreditation, but only 2 out of ~14 IVF facilities have documented international accreditation
    • Prof. Khaldoun Sharif (FRCOG, FACOG, 100+ publications, former Birmingham Women's Hospital Clinical Director) represents world-class specialist leadership comparable to Score 5, but is not representative of the sector overall
    • No mandatory national ART registry or success-rate reporting requirement; clinics self-certify outcomes; large discrepancy between self-reported rates (57% <35) and verified rates (14.1% overall)

    Read the full Jordan report →

  17. 17 Mexico MX 3.0/5 Moderate Mexico's IVF sector presents mixed quality with adequate success rates (40-50% for women under 35) at leading clinics, but significant safety and transparency concerns undermine overall assessment. The critically low ... Full report
    The evidence behind this score 7 cited points
    • Live birth rates of 40-50% for women under 35, competitive with Score 4 threshold, but with reliability concerns due to transparency issues
    • Single embryo transfer rate of only 3.11% with 20.78% twin and 0.92% triplet rates, indicating suboptimal embryo transfer practices and elevated patient safety risks
    • Only 1-2 fertility-specific JCI-accredited clinics, falling below Score 4 requirement of 2-4 JCI clinics
    • OHSS rates of 6.7% in conventional IVF exceed international standards of <5%, aligning with Score 3 range (5-8%)
    • Mandatory national IVF registry absent; REDLARA participation is voluntary with only 50-60% of all ART centers reporting
    • Documented massive discrepancy: clinics advertise 60-96% success rates while independent field study found actual 21.9% pregnancy rate and 10.8% live birth rate per cycle
    • Voluntary specialty certification in reproductive medicine creates inconsistent training standards, with CONACEM certification optional rather than mandatory

    Read the full Mexico report →

  18. 18 Turkey TR 3.0/5 Moderate Turkey demonstrates moderate IVF quality with strong safety outcomes and extensive international accreditation, but success rates and outcome transparency limit its rating. Clinical pregnancy rates of 31.6-43.9% for f... Full report
    The evidence behind this score 5 cited points
    • Clinical pregnancy rates 31.6-43.9% for fresh embryo transfers with fresh cycle success at 30.6%, within Score 3 range of 30-40% for women under 35
    • Exceptional safety record with >99.6% of IVF cycles completed without serious OHSS complications (<0.4% rate), far exceeding international benchmarks
    • Extensive international accreditation with 50+ JCI-accredited hospitals and ISO-certified facilities, exceeding Good threshold requirements
    • Lack of publicly accessible national IVF registry; success rates submitted to Ministry of Health but not available publicly, with reporting to European registries stopped after 2012
    • Mandatory 6-month Ministry of Health-approved training for IVF physicians with regular 6-monthly inspections, though training period is shorter than 3-year fellowship requirements in leading countries

    Read the full Turkey report →

  19. 19 Hungary HU 2.5/5 Moderate Hungary's IVF quality profile reflects a system in transition with significant deficiencies in access and outcomes but emerging strengths in regulation and one world-class outlier. State hospital success rates (23.6% ... Full report
    The evidence behind this score 5 cited points
    • Live birth rates 23.6% overall in 2023, down from 19% in 2019 and 16% in 2021—well below EU average of 33%
    • Only one clinic with international accreditation: Versys Clinics holding ESHRE ART Centre Certification for Good Practice (one of ~4 globally), but largely inaccessible to foreign patients post-July 2022 nationalization
    • No ESHRE-accredited subspecialist training centers in Hungary; general gynecologists with fertility training or emerging specialists dominate
    • Multiple pregnancy rate of 12.5% in 2023 indicates partial compliance with single embryo transfer mandates; above sub-10% international best practice
    • New mandatory national ART registry introduced 2023 but first comprehensive report not expected until 2026; outcome data historically incomplete

    Read the full Hungary report →

Reading the field

What separates a good programme from a dangerous one

Every country above is graded against this published scale — the same 1–5 rubric for ivf quality, top to bottom. How we score →

  1. 5/5 Excellent

    - Live birth rates >50% for women under 35, >40% for 35-37, >30% for 38-40 - 80%+ single embryo transfer rate indicating quality practices - Multiple internationally accredited clinics (5+ JCI or equivalent) - Board-certified reproductive endocrinologists with 10+ years experience - Comprehensive national IVF registry with transparent outcome reporting - Laboratory quality systems meeting international standards (ISO 15189 or equivalent) - OHSS rates <3% indicating safe stimulation protocols - Active research participation and publication in peer-reviewed journals

  2. 4/5 Good

    - Live birth rates 40-50% for women under 35, 30-40% for 35-37, 20-30% for 38-40 - 60-80% single embryo transfer rate - Some internationally accredited clinics (2-4 JCI or equivalent) - Qualified reproductive specialists with subspecialty training - Regional outcome reporting or clinic-specific success rate transparency - Laboratory accreditation or quality certification programs - OHSS rates 3-5% with established management protocols - Some participation in international fertility conferences and research

  3. 3/5 Moderate

    - Live birth rates 30-40% for women under 35, 20-30% for 35-37, 15-25% for 38-40 - 40-60% single embryo transfer rate - Limited international accreditation (1-2 clinics) - General gynecologists with fertility training or emerging reproductive specialists - Basic outcome tracking at institutional level - Standard laboratory practices meeting national requirements - OHSS rates 5-8% with adequate management capabilities - Participation in regional fertility networks

  4. 2/5 Poor

    - Live birth rates 20-30% for women under 35, 15-25% for 35-37, 10-20% for 38-40 - <40% single embryo transfer rate indicating suboptimal practices - Minimal international recognition or accreditation - Limited specialist training in reproductive medicine - Inconsistent or unclear outcome reporting - Basic laboratory facilities with limited quality oversight - OHSS rates 8-12% suggesting protocol issues - Limited continuing education or professional development

  5. 1/5 Very Poor / Unavailable

    - Live birth rates <20% for women under 35, <15% for 35-37, <10% for 38-40 - High multiple birth rates indicating poor embryo transfer practices - No international accreditation or quality recognition - Inadequate physician training in reproductive medicine - No systematic outcome tracking or reporting - Substandard laboratory conditions or practices - High complication rates or inadequate safety protocols - No participation in professional fertility organizations

The reports

The full country reports under this lens

Each destination we have assessed has a full, cited report — the detailed analysis behind its score. The verdict is free; the report is the depth.

Clinics & providers

The clinics our research names

Named hospitals, clinics and centres cited across these findings — each carrying the specialties our reports record. Follow one to the reports behind it.

References

The sources behind these assessments

The distinct sources cited across these published reports — every finding carries its own citations; this is the union, each linking back to the reports that lean on it.

  1. Untitled source www.thailawforum.com/thailand-draft-surrogacy-law Cited in IVF Quality in Thailand
  2. Untitled source academic.oup.com/humrep/article/27/12/3365/653252 Cited in IVF Quality in Turkey
  3. Untitled source altrus.org/how-to-verify-if-a-doctor-is-board-certified-in-mexico Cited in IVF Quality in Mexico
  4. Untitled source archive.cdc.gov/www_cdc_gov/art/reports/2019/pdf/2019-Report-ART-Fertility-Clinic-National-Summary-h.pdf Cited in IVF Quality in United States
  5. Untitled source aveya.in/single-embryo-transfer-set-vs-multiple-embryo-transfer-risks-and-benefits Cited in IVF Quality in India
  6. Untitled source aveya.in/single-vs-multiple-embryo-transfer Cited in IVF Quality in India
  7. Untitled source bangkokfertilitycenter.com/blog/ivf-success-rate-in-bangkok Cited in IVF Quality in Thailand
  8. Untitled source bangkokfertilitycenter.com/blog/ivf-success-rate-in-thailand Cited in IVF Quality in Thailand
  9. Untitled source bestclinicabroad.com/en/clinics/south-korea/reproductive-medicine Cited in IVF Quality in South Korea
  10. Untitled source blog.creliohealth.com/iso-standards-certifications-everything-you-need-to-know Cited in IVF Quality in India
  11. Untitled source bookinghealth.com/blog/diagnoses-and-treatment/diagnosis-and-treatment/603670-benefits-of-ivf-in-korea.html Cited in IVF Quality in South Korea
  12. Untitled source britishmedicallab.com/en/certifications Cited in IVF Quality in Turkey
  13. Untitled source certvalue.com/iso-17025-certification-in-turkey Cited in IVF Quality in Turkey
  14. Untitled source chedidgrieco.com/fertilization-clinic-sao-paulo-brazil Cited in IVF Quality in Brazil
  15. Untitled source college.mayo.edu/academics/residencies-and-fellowships/reproductive-endocrinology-and-infertility-fellowship-minnesota/curriculum Cited in IVF Quality in India
  16. Untitled source community.icloudhospital.com/t/can-you-provide-information-on-the-availability-and-success-rates-of-fertility-treatments-such-as-in-vitro-fertilization-ivf-in-south-korea/2602 Cited in IVF Quality in South Korea
  17. Untitled source draksoyivf.com/blog/ivf-turkey-safety-quality-cost-guide Cited in IVF Quality in Turkey
  18. Untitled source embryo.asu.edu/pages/south-koreas-bioethics-and-biosafety-act-2005 Cited in IVF Quality in South Korea
  19. Untitled source embryologytraining.in Cited in IVF Quality in India
  20. Untitled source emedicine.medscape.com/article/1343572-overview Cited in IVF Quality in India
  21. Untitled source en.wikipedia.org/wiki/Medical_tourism_in_India Cited in IVF Quality in India
  22. Untitled source en.wikipedia.org/wiki/National_Accreditation_Board_for_Testing_and_Calibration_Laboratories Cited in IVF Quality in India
  23. Untitled source en.wikipedia.org/wiki/Ovarian_hyperstimulation_syndrome Cited in IVF Quality in India, IVF Quality in Turkey
  24. Untitled source en.wikipedia.org/wiki/Reproductive_endocrinology_and_infertility Cited in IVF Quality in India, IVF Quality in Turkey, IVF Quality in United States

Explore the source archive →

In plain language

Start exploring the knowledge base

The field's shorthand our reports use, sized by how often it comes up. Follow any term to its full entry and the reports that use it.

For readers weighing this decision

Ways to read the evidence

The verdict is always free. A membership opens the full analysis and every cited source — this specialty, the whole library, or everything for good.

  • One specialty · annual

    Reproductive Services

    $49.00 / year

    $49.00/year

    Every report in this specialty — full analysis and every cited source — as each is published.

    Take this specialty

  • Full library · annual

    The whole library

    $199.00 / year

    $199.00/year

    The complete evidence behind every finding in every specialty, while your decision is live.

    Take the full library
  • Most readers

    Lifetime · one payment

    Everything, for good

    $499.00 once

    $499.00 (one-time)

    Every finding we publish today and hereafter — no renewal, no expiry. The tier we point most readers to.

    Take lifetime access

Prefer to pay per report? A single report is $29.00, yours to keep — browse the reports. The verdict is always free.

Where to go from here · IVF Quality

no scope is a dead end — step up to the specialty, drill into a factor, or pivot across to a country or a comparison